Oghalai John S, Leung Man-Kit, Jackler Robert K, McDermott Michael W
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, USA.
Otol Neurotol. 2004 Jul;25(4):570-9; discussion 579. doi: 10.1097/00129492-200407000-00026.
To elucidate indications and outcomes with the transjugular craniotomy for resection of jugular foramen tumors with intracranial extension. The transjugular approach is a lateral craniotomy conducted through a partial petrosectomy traversing the jugular fossa combined with resection of the sigmoid sinus and jugular bulb, which often have been occluded by disease.
Retrospective review.
University medical center.
Twenty-eight patients with intracranial jugular foramen tumors who underwent a total of 30 surgical procedures.
Pathologic findings, surgical approach, extent of tumor resection, rate of facial nerve mobilization and ear canal closure, facial and lower cranial nerve outcomes, and hearing preservation.
Tumors included schwannoma (37%), meningioma (33%), glomus jugulare (23%), and chordoma (7%). The surgical approaches were tailored to maximize functional preservation, and included the transjugular (53%), translabyrinthine (17%), retrosigmoid (10%), and far lateral (7%) craniotomies. Translabyrinthine (3%) or transcondylarfar lateral (3%) approaches were occasionally used in combination with the trans-jugular approach. Most procedures were managed in a single stage (90%), but three patients with massive tumor in the neck required two stages. Microsurgical gross total and near-total tumor removal (37% each) were commonly achieved, although subtotal resections (27%) were occasionally performed. In only a minority of cases was facial nerve mobilization (7%) or ear canal closure (21%) required. If present preoperatively, Grade I facial nerve function was usually maintained (22 of 24 [92%]) and Hearing Class A or B could always be maintained (9 of 9 [100%]). As expected, new lower cranial nerve dysfunction was common (8 of 30 [27%]), although over half of the patients had complete lower nerve palsy preoperatively (16 of 30 [53%]).
Most patients with jugular foramen tumors with intracranial extension can be managed with a single-stage transjugular craniotomy. Facial nerve mobilization or ear canal closure is usually not required, permitting conservation of facial function and hearing, when present preoperatively.
阐明经颈静脉开颅术切除侵犯颅内的颈静脉孔区肿瘤的适应证及手术效果。经颈静脉入路是一种外侧开颅术,通过部分岩骨切除术穿过颈静脉窝,并联合切除通常已被病变阻塞的乙状窦和颈静脉球。
回顾性研究。
大学医学中心。
28例患有颅内颈静脉孔区肿瘤的患者,共接受了30次手术。
病理结果、手术入路、肿瘤切除范围、面神经游离和耳道封闭率、面神经及低位颅神经功能转归以及听力保留情况。
肿瘤包括神经鞘瘤(37%)、脑膜瘤(33%)、颈静脉球瘤(23%)和脊索瘤(7%)。手术入路根据功能保留最大化原则进行调整,包括经颈静脉入路(53%)、经迷路入路(17%)、乙状窦后入路(10%)和远外侧入路(7%)。偶尔会将经迷路入路(3%)或经髁远外侧入路(3%)与经颈静脉入路联合使用。大多数手术为一期完成(90%),但3例颈部有巨大肿瘤的患者需要分两期进行。通常能实现显微外科全切除和近全切除肿瘤(各占37%),不过偶尔也会进行次全切除(27%)。仅少数病例需要面神经游离(7%)或耳道封闭(21%)。若术前存在I级面神经功能,通常可得以保留(24例中的22例[92%]),且始终能保留A或B级听力(9例中的9例[100%])。不出所料,新出现的低位颅神经功能障碍较为常见(30例中的8例[27%]),尽管超过半数患者术前存在完全性低位颅神经麻痹(30例中的16例[53%])。
大多数侵犯颅内的颈静脉孔区肿瘤患者可通过一期经颈静脉开颅术进行治疗。通常无需进行面神经游离或耳道封闭,从而在术前存在面神经功能和听力的情况下得以保留这些功能。